Bathiya Ratnayake

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Sanjay Pandanaboyana · 7 shared papers, 2020–2024 · strength 1.20
   • Paper Upfront surgery vs. neoadjuvant therapy for resectable pancreatic cancer: a narrative review of available evidence. DOI 10.21037/cco-21-161↗
   • Paper Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review. DOI 10.1016/j.hpb.2024.02.001↗
   • Paper Patient volume and clinical outcome after pancreatic cancer resection: A contemporary systematic review and meta-analys… DOI 10.1016/j.surg.2021.11.029↗
2. John Albert Windsor · 3 shared papers, 2020–2022 · strength 0.43
   • Paper Patient volume and clinical outcome after pancreatic cancer resection: A contemporary systematic review and meta-analys… DOI 10.1016/j.surg.2021.11.029↗
   • Paper The Impact of the Depth of Venous Invasion on Survival Following Pancreatoduodenectomy for Pancreatic Cancer: a Meta-an… DOI 10.1007/s12029-019-00248-3↗
   • Paper Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant… DOI 10.3390/jcm9072132↗
3. Keith John Roberts · 2 shared papers, 2020–2022 · strength 0.38
   • Paper Upfront surgery vs. neoadjuvant therapy for resectable pancreatic cancer: a narrative review of available evidence. DOI 10.21037/cco-21-161↗
   • Paper Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant… DOI 10.3390/jcm9072132↗
4. Benjamin P. T. Loveday · 2 shared papers, 2020–2021 · strength 0.28
   • Paper The Impact of the Depth of Venous Invasion on Survival Following Pancreatoduodenectomy for Pancreatic Cancer: a Meta-an… DOI 10.1007/s12029-019-00248-3↗
   • Paper Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-an… DOI 10.1080/17474124.2021.1884544↗
5. Francis P. Robertson · 1 shared paper, 2024 · strength 0.23
   • Paper Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review. DOI 10.1016/j.hpb.2024.02.001↗
6. Nigel Balfour Jamieson · 1 shared paper, 2024 · strength 0.23
   • Paper Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review. DOI 10.1016/j.hpb.2024.02.001↗
7. Jonathan Koea · 1 shared paper, 2022 · strength 0.16
   • Paper Patient volume and clinical outcome after pancreatic cancer resection: A contemporary systematic review and meta-analys… DOI 10.1016/j.surg.2021.11.029↗
8. Sayali A. Pendharkar · 1 shared paper, 2022 · strength 0.16
   • Paper Patient volume and clinical outcome after pancreatic cancer resection: A contemporary systematic review and meta-analys… DOI 10.1016/j.surg.2021.11.029↗
9. Derek Manas · 1 shared paper, 2021 · strength 0.15
   • Paper Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review. DOI 10.3390/cancers13133212↗
10. John Samuel Leeds · 1 shared paper, 2021 · strength 0.13
    • Paper Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-an… DOI 10.1080/17474124.2021.1884544↗
11. Kofi W. Oppong · 1 shared paper, 2021 · strength 0.13
    • Paper Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-an… DOI 10.1080/17474124.2021.1884544↗
12. Khaled Ammar · 1 shared paper, 2021 · strength 0.13
    • Paper Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-an… DOI 10.1080/17474124.2021.1884544↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.